A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Clinical trial NCT06873945 · RECRUITING

Trial details

NCT number: NCT06873945
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2025-04-01
Primary completion: 2028-03-19
Enrollment: 1330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.